SCHEMBL6950191

SCHEMBL6950191

COc1ccccc1CCC(=O)NCC(Cc1ccccc1)NC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
CTSG P08311 1/20 0.48
CMA1 P23946 1/20 0.48
TAAR1 Q96RJ0 1/20 0.46
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
ITGA4 P13612 1/20 0.43
ITGB7 P26010 1/20 0.43
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6307079 0.85 MAPT (0.54) HPGDMEN1KMT2A
SCHEMBL7086322 0.85 MAPT (0.54) HPGDMEN1KMT2A
SCHEMBL6949954 0.83 HPGD (0.46) HPGDTAAR1MEN1NPC1RAB9A
SCHEMBL6949610 0.83 HPGD (0.46) HPGDTAAR1MEN1NPC1RAB9A
SCHEMBL6953117 0.79 MEN1 (0.54) MEN1KMT2AALDH1A1GAAITGA4
SCHEMBL6950194 0.75 TACR1 (0.58)
SCHEMBL23350083 0.71 MTNR1A (0.59) HPGDMEN1NPC1RAB9AKMT2A
SCHEMBL30740884 0.71 MTNR1A (0.59) HPGDMEN1NPC1RAB9AKMT2A
SCHEMBL6949603 0.71 NPC1 (0.45) HPGDTAAR1NPC1RAB9AKMT2A
SCHEMBL3208001 0.71 TAAR1 (0.59) HPGDTAAR1MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699665-B1 Imidazoline derivatives, their preparation and their use as tachykinin receptor antagonists LILLY CO ELI (US) 2003-03-05 EP disclosed
US-6175013-B1 1-(2-METHOXYBENZYL)-2-((4-PHENYL-1-PIPERAZINYL)METHYL)-4-(1H -INDOL-3-YLMETHYL)-2-IMIDAZOLINE, FOR EXAMPLE; ADMINSTERING TO TREAT ANXIETY, DEPRESSION, PSYCHOSIS, AND SCHIZOPHRENIA ELI LILLY AND COMPANY 2001-01-16 US disclosed
EP-0699665-A1 Imidazoline derivatives, their preparation and their use as tachykinin receptor antagonists ELI LILLY AND COMPANY (US) 1996-03-06 EP disclosed